8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Mar 26, 2026·SEC
Material company update
Mar 2, 2026·SEC
DBV Technologies S.A.(DBVT)Earnings, Financials & Key Ratios
DBVT•NASDAQ
Price updated Jun 19, 2026
AboutDBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.Show more
- Revenue$0
- EBITDA-$135M-19.2%
- Net Income-$147M-29.6%
- EPS (Diluted)-26.40-347.5%
- ROE-150.29%-10.7%
DBVT Key Insights
DBV Technologies S.A. (DBVT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Share count reduced 71.0% through buybacks
- ✓Trading at only 0.5x book value
✗Weaknesses
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when DBVT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DBVT Price & Volume
DBV Technologies S.A. (DBVT) stock price & volume — 10-year historical chart
Loading chart...
DBVT Growth Metrics
DBV Technologies S.A. (DBVT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-100%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-47.7%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM11.82%
Return on Capital
10 Years-80.79%
5 Years-87.77%
3 Years-107.22%
Last Year-145.72%
DBVT Recent Earnings
DBV Technologies S.A. (DBVT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$0.56-300.0%
$0.14
Rev
$1M-4.9%
$1M
Q2 2026
Mar 27, 2026Metric
Actual
Est
EPS
$1.15+11.5%
$1.30
Rev
$574,600-60.5%
$1M
Q2 2026
Mar 26, 2026Metric
Actual
Est
EPS
$1.15+11.5%
$1.30
Rev
$574,600-60.5%
$1M
Q4 2025
Oct 28, 2025Metric
Actual
Est
EPS
$1.20+17.2%
$1.45
Rev
$3M+204.5%
$1M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.56vs $0.14-300.0% | $1Mvs $1M-4.9% |
| Q2 2026 | Mar 27, 2026 | $1.15vs $1.30+11.5% | $574,600vs $1M-60.5% |
| Q2 2026 | Mar 26, 2026 | $1.15vs $1.30+11.5% | $574,600vs $1M-60.5% |
| Q4 2025 | Oct 28, 2025 | $1.20vs $1.45+17.2% | $3Mvs $1M+204.5% |
Based on last 12 quarters of dataView full earnings history →
DBVT Peer Comparison
DBV Technologies S.A. (DBVT) competitors in Immunology and Inflammation Therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ALKS | 7.5B | 44.99 | 31.46 | -5.25% | 9.78% | 8.82% | 0.04 | |
 PRGO | 1.42B | 10.25 | -1.00 | -2.75% | -43.5% | -50.65% | 1.35 | |
 SLRX | 697.79K | 0.74 | -0.01 | -117.81% | 0.15 | |||
 SNGX | 4.12M | 0.40 | -0.19 | -246.04% | 0.07 | |||
 HALO | 8.13B | 68.55 | 26.78 | 37.55% | 23.13% | 126.27% | 43.89 | |
 ALK | 5.65B | 49.26 | 56.62 | 21.34% | 0.7% | 2.43% | 1.67 | |
 REGN | 63.37B | 609.94 | 14.70 | 0.99% | 29.65% | 14.32% | 0.09 | |
 SANA | 876.62M | 3.15 | -3.28 | -161.87% | 0.49 |
Compare DBVT vs Peers
DBV Technologies S.A. (DBVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DBVT Income Statement
DBV Technologies S.A. (DBVT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 11.52M | 12.81M | 14.71M | 11.28M | 5.71M | 4.8M | 15.73M | 0 | 0 | 0 |
Revenue Growth % | 45.31% | 11.25% | 14.77% | -23.33% | -49.38% | -15.91% | 227.67% | -100% | - | -100% |
Cost of Goods Sold | 3.43M | 5.03M | 0 | 0 | 9.27M | 20.3M | 0 | 6.81M | 17.67M | 13.18M |
COGS % of Revenue | 29.8% | 39.27% | - | - | 162.46% | 422.9% | - | - | - | - |
Gross Profit | 11.52M▲ 0% | 12.81M▲ 11.3% | 14.71M▲ 14.8% | 11.28M▼ 23.3% | -3.56M▼ 131.6% | -15.5M▼ 334.8% | 15.73M▲ 201.5% | -6.81M▼ 143.3% | -17.67M▼ 159.4% | -13.18M▲ 0% |
Gross Margin % | 100% | 100% | 100% | 100% | -62.46% | -322.9% | 100% | - | - | - |
Gross Profit Growth % | 45.31% | 11.25% | 14.77% | -23.33% | -131.62% | -334.75% | 201.48% | -143.32% | -159.39% | - |
Operating Expenses | 185.46M | 203.22M | 192.8M | 170.12M | 93.93M | 101.47M | 92.16M | 113.71M | 135.49M | 151.58M |
OpEx % of Revenue | 1610.07% | 1585.77% | 1310.86% | 1508.67% | 1645.6% | 2114.06% | 585.96% | - | - | - |
Selling, General & Admin | 61.47M | 82.19M | 70.73M | 44.96M | 23.83M | 17.56M | 31.94M | 23.81M | 28.37M | 30.49M |
SG&A % of Revenue | 533.65% | 641.33% | 480.89% | 398.72% | 417.43% | 365.9% | 203.06% | - | - | - |
Research & Development | 126.25M | 123.5M | 112.24M | 101.61M | 70.34M | 75.5M | 60.22M | 89.9M | 107.12M | 121.86M |
R&D % of Revenue | 1096.04% | 963.68% | 763.13% | 901.09% | 1232.24% | 1572.92% | 382.9% | - | - | - |
Other Operating Expenses | -5.21M | -6.96M | 9.83M | 23.55M | -232K | 8.41M | -1K | 0 | 1 | -763.21K |
Operating Income | -173.94M▲ 0% | -190.12M▼ 9.3% | -171.02M▲ 10.0% | -158.84M▲ 7.1% | -98.61M▲ 37.9% | -96.63M▲ 2.0% | -76.43M▲ 20.9% | -120.53M▼ 57.7% | -153.16M▼ 27.1% | -124.76M▲ 0% |
Operating Margin % | -1509.99% | -1483.57% | -1162.79% | -1408.67% | -1727.65% | -2013.15% | -485.96% | - | - | - |
Operating Income Growth % | -42.42% | -9.3% | 10.04% | 7.12% | 37.92% | 2.01% | 20.9% | -57.69% | -27.08% | - |
EBITDA | -170.64M | -186.88M | -168.43M | -148.38M | -90.24M | -76.33M | -63.27M | -113.71M | -135.49M | -111.58M |
EBITDA Margin % | -1481.34% | -1458.31% | -1145.15% | -1315.9% | -1580.9% | -1590.25% | -402.28% | - | - | - |
EBITDA Growth % | -41.45% | -9.52% | 9.87% | 11.9% | 39.18% | 15.41% | 17.11% | -79.73% | -19.15% | -3.58% |
D&A (Non-Cash Add-back) | 3.3M | 3.24M | 2.6M | 10.46M | 8.38M | 20.3M | 13.16M | 6.81M | 17.67M | 13.18M |
EBIT | -173.36M | -190.43M | -171.02M | -135.29M | -99.53M | -96.98M | -76.43M | -117.8M | -153.16M | -124.55M |
Net Interest Income | -3.25M | 162.44K | -377.93K | -724K | -169K | -20.71K | 3.71M | 2.73M | 601.86K | 1.05M |
Interest Income | 867.09K | 563.94K | 0 | 0 | 521K | 406.29K | 3.71M | 2.73M | 601.86K | 1.7M |
Interest Expense | 3.99M | 479.76K | 377.93K | 724K | 690K | 427K | 0 | 0 | 0 | 656.16K |
Other Income/Expense | -3.25M | 161.53K | -378K | -723K | 424K | 427K | 3.71M | 2.73M | 601.86K | -47.45M |
Pretax Income | -177.11M▲ 0% | -190.24M▼ 7.4% | -171.4M▲ 9.9% | 159.56M▲ 193.1% | -98.19M▼ 161.5% | -96.2M▲ 2.0% | -72.72M▲ 24.4% | -117.8M▼ 62.0% | -152.56M▼ 29.5% | -172.21M▲ 0% |
Pretax Margin % | -1537.56% | -1484.52% | -1165.35% | 1415.09% | -1720.22% | -2004.25% | -462.35% | - | - | - |
Income Tax | 1.2K | 17.16K | 610K | 10K | -381K | 70K | 7K | -4.08M | -5.16M | -4.4M |
Effective Tax Rate % | -0% | -0.01% | -0.36% | 0.01% | 0.39% | -0.07% | -0.01% | 3.47% | 3.38% | 2.55% |
Net Income | -177.2M▲ 0% | -190.26M▼ 7.4% | -172.01M▲ 9.6% | -159.56M▲ 7.2% | -97.81M▲ 38.7% | -96.3M▲ 1.5% | -72.73M▲ 24.5% | -113.72M▼ 56.4% | -147.4M▼ 29.6% | -167.81M▲ 0% |
Net Margin % | -1538.29% | -1484.65% | -1169.51% | -1415% | -1713.54% | -2006.25% | -462.4% | - | - | - |
Net Income Growth % | -40.25% | -7.37% | 9.59% | 7.24% | 38.7% | 1.54% | 24.48% | -56.36% | -29.62% | -47.7% |
Net Income (Continuing) | -177.2M | -190.26M | -172.01M | -159.56M | -98.05M | -96.27M | -72.73M | -113.72M | -147.4M | -167.81M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -42.00▲ 0% | -39.25▲ 6.5% | -26.40▲ 32.7% | -14.75▲ 44.1% | -8.90▲ 39.7% | -6.20▲ 30.3% | -3.80▲ 38.7% | -5.90▼ 55.3% | -26.40▼ 347.5% | 0.00▲ 0% |
EPS Growth % | -757.14% | 6.55% | 32.74% | 44.13% | 39.66% | 30.34% | 38.71% | -55.26% | -347.46% | 11.82% |
EPS (Basic) | -42.00 | -39.25 | -26.40 | -14.75 | -8.90 | -6.20 | -3.80 | -5.90 | -26.40 | - |
Diluted Shares Outstanding | 4.95M | 5.79M | 7.4M | 10.82M | 11.02M | 15.48M | 19.02M | 19.23M | 5.58M | 85.66T |
Basic Shares Outstanding | 4.95M | 5.79M | 7.4M | 10.82M | 11.02M | 15.48M | 19.02M | 19.23M | 5.58M | 85.66T |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
DBVT Balance Sheet
DBV Technologies S.A. (DBVT) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 220.81M | 198.83M | 204.55M | 207.37M | 114.52M | 223.07M | 158.91M | 44.39M | 212.94M | 246.7M |
Cash & Short-Term Investments | 194.08M | 167.81M | 193.25M | 196.35M | 77.3M | 209.19M | 141.37M | 32.46M | 194.17M | 229.2M |
Cash Only | 194.08M | 167.81M | 193.25M | 196.35M | 77.3M | 209.19M | 141.37M | 32.46M | 194.17M | 229.2M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 19.87M | 20.15M | 5.41M | 7.86M | 33.07M | 10.49M | 15.45M | 10.39M | 16.15M | 0 |
Days Sales Outstanding | 629.47 | 574.04 | 134.23 | 254.43 | 2.11K | 798 | 358.43 | - | - | - |
Inventory | 2.89M | 2.14M | 2.29M | 0 | 0 | 2.68M | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | 307.4 | 155.23 | - | - | - | 48.19 | - | - | - | - |
Other Current Assets | 20.79M | 25.25M | 0 | 0 | 0 | 1K | 0 | 0 | 0 | 17.5M |
Total Non-Current Assets | 29.48M | 35.92M | 67.17M | 64.87M | 31.81M | 23.44M | 24.07M | 21.27M | 20.77M | 19.7M |
Property, Plant & Equipment | 25.07M | 27.64M | 48.6M | 34.9M | 24.92M | 17.61M | 17.93M | 16.81M | 14.95M | 14.1M |
Fixed Asset Turnover | 0.46x | 0.46x | 0.30x | 0.32x | 0.23x | 0.27x | 0.88x | - | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 661 | 0 | 0 | 0 | 0 |
Intangible Assets | 173.14K | 41.01K | 48K | 41K | 22K | 9.34K | 58K | 40K | 22K | 100K |
Long-Term Investments | 1.88M | 590.48K | 5.12M | 4.58M | 3.97M | 1.66M | 3.68M | 4.31M | 620K | 620K |
Other Non-Current Assets | 1.55M | 5.78M | 13.41M | 25.35M | 2.9M | 5.83M | 2.4M | 111K | 5.19M | 5.5M |
Total Assets | 250.28M▲ 0% | 234.76M▼ 6.2% | 271.73M▲ 15.7% | 272.25M▲ 0.2% | 146.32M▼ 46.3% | 246.52M▲ 68.5% | 182.99M▼ 25.8% | 65.66M▼ 64.1% | 233.72M▲ 256.0% | 266.4M▲ 0% |
Asset Turnover | 0.05x | 0.05x | 0.05x | 0.04x | 0.04x | 0.02x | 0.09x | - | - | 0.00x |
Asset Growth % | -21.09% | -6.2% | 15.75% | 0.19% | -46.25% | 68.48% | -25.77% | -64.12% | 255.96% | 727.19% |
Total Current Liabilities | 50.58M | 59.52M | 54M | 52.71M | 31.4M | 29.52M | 37.34M | 31.14M | 58.02M | 51.8M |
Accounts Payable | 23.85M | 39.05M | 24M | 20.34M | 11.43M | 14.47M | 23.3M | 22.03M | 40.94M | 0 |
Days Payables Outstanding | 2.54K | 2.83K | - | - | 449.9 | 260.24 | - | 1.18K | 845.48 | 841.45 |
Short-Term Debt | 3.89M | 3.49M | 4.33M | 4.43M | 3.51M | 1.13M | 883K | 846K | 16.27M | 0 |
Deferred Revenue (Current) | 3.93M | 5.96M | 3.6M | 4.69M | 4.15M | 2.14M | 0 | 0 | 0 | 0 |
Other Current Liabilities | 18.31M | 2.92M | 21.63M | 22.68M | 12.13M | 9.82M | 11.79M | 7.42M | 217K | 51.8M |
Current Ratio | 4.37x | 3.34x | 3.79x | 3.93x | 3.65x | 7.56x | 4.26x | 1.43x | 3.67x | 4.76x |
Quick Ratio | 4.31x | 3.30x | 3.75x | 3.93x | 3.65x | 7.47x | 4.26x | 1.43x | 3.67x | 4.76x |
Cash Conversion Cycle | -1.6K | -2.1K | - | - | - | 585.95 | - | - | - | - |
Total Non-Current Liabilities | 16.83M | 9.46M | 24.54M | 14.04M | 15.9M | 22.54M | 5.46M | 7.13M | 6.92M | 6.7M |
Long-Term Debt | 2.57M | 1.75M | 810K | 543K | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 22M | 10.5M | 7.15M | 1.13M | 4.53M | 6.3M | 5.41M | 18.8M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 14.26M | 7.71M | 1.74M | 3M | 8.75M | 21.42M | 934K | 838K | 1.51M | 6.7M |
Total Liabilities | 67.4M | 68.98M | 78.54M | 66.75M | 47.29M | 52.06M | 42.8M | 38.27M | 64.95M | 58.4M |
Total Debt | 6.46M | 5.24M | 27.14M | 15.47M | 10.66M | 4.15M | 6.55M | 7.8M | 21.68M | 0 |
Net Debt | -187.62M | -162.57M | -166.12M | -180.88M | -66.64M | -205.04M | -134.81M | -24.66M | -172.48M | -229.2M |
Debt / Equity | 0.04x | 0.03x | 0.14x | 0.08x | 0.11x | 0.02x | 0.05x | 0.28x | 0.13x | 0.00x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 2.05x |
Interest Coverage | -43.46x | -396.92x | -452.53x | -186.87x | -144.25x | -227.12x | - | - | - | -189.82x |
Total Equity | 182.88M▲ 0% | 165.78M▼ 9.4% | 193.19M▲ 16.5% | 205.49M▲ 6.4% | 99.03M▼ 51.8% | 194.45M▲ 96.4% | 140.19M▼ 27.9% | 27.39M▼ 80.5% | 168.77M▲ 516.2% | 207.9M▲ 0% |
Equity Growth % | -31.74% | -9.35% | 16.53% | 6.37% | -51.81% | 96.36% | -27.91% | -80.46% | 516.22% | 7659.39% |
Book Value per Share | 36.94 | 28.66 | 26.10 | 18.99 | 8.99 | 12.56 | 7.37 | 1.42 | 30.23 | 0.00 |
Total Shareholders' Equity | 182.88M | 165.78M | 193.19M | 205.49M | 99.03M | 194.45M | 140.19M | 27.39M | 168.77M | 207.9M |
Common Stock | 3.52M | 4.12M | 5.64M | 6.52M | 6.54M | 10.72M | 10.97M | 11.65M | 26.08M | 33M |
Retained Earnings | -207.9M | -227M | -798.99M | -958.54M | -98.05M | -259.58M | -238.86M | -286.38M | -393.13M | -440.7M |
Treasury Stock | 0 | 0 | -230K | -1.17M | 0 | -1.11M | -1.26M | -1.31M | 0 | 0 |
Accumulated OCI | -185.23M | -348.47M | -643.87M | 6.64M | -15.39M | -13.8M | -8.13M | -12.19M | -5.43M | 400K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DBVT Cash Flow Statement
DBV Technologies S.A. (DBVT) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -160.91M | -186.74M | -148.35M | -165.61M | -108.24M | -55.7M | -79.65M | -104.47M | -121.18M | -150.63M |
Operating CF Margin % | -1396.92% | -1457.2% | -1008.61% | -1468.67% | -1896.32% | -1160.42% | -506.44% | - | - | - |
Operating CF Growth % | -144.99% | -16.05% | 20.56% | -11.63% | 34.64% | 48.54% | -43% | -31.16% | -15.99% | -378% |
Net Income | -207.9M | -227M | -172.01M | -159.56M | -97.81M | -96.27M | -72.73M | -113.92M | -146.95M | -167.81M |
Depreciation & Amortization | 4.12M | 3.87M | 2.6M | 10.46M | 8.38M | 13.16M | -14M | -925K | 3.19M | 5.65M |
Stock-Based Compensation | 43.33M | 35.41M | 17.24M | -1.13M | 3.12M | 5.03M | 6.02M | 4.62M | 5.39M | 9.45M |
Deferred Taxes | 323.75K | 403.22K | 0 | 0 | 184K | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 182.99K | 1.03M | 381K | 220K | 656K | 66K | 99K | -3K | 15.84M | 102.5M |
Working Capital Changes | -968.44K | -445.6K | 3.45M | -15.6M | -22.77M | 22.32M | 953K | 5.75M | 1.34M | 1.36M |
Change in Receivables | 4.22K | 1.68M | 34K | -2.07M | 2.15M | 0 | 0 | 0 | 0 | 0 |
Change in Inventory | -5M | -2.14M | -527K | 2.33M | -16.18M | 0 | 0 | 0 | -16.11M | -8.77M |
Change in Payables | 4.69M | 12.43M | -7.65M | -5.08M | -7.56M | 3.46M | 8.42M | 272K | 15.83M | 4.83M |
Cash from Investing | -11.03M | -11.81M | -5.66M | -2.87M | -433K | -100K | -808K | -757K | -1.37M | -1.3M |
Capital Expenditures | -10.62M | -6.49M | -5.57M | -2.79M | -918K | -754K | -677K | -2.34M | 0 | -149K |
CapEx % of Revenue | 92.2% | 50.67% | 37.85% | 24.73% | 16.08% | 15.71% | 4.3% | - | - | - |
Acquisitions | 0 | 0 | 0 | 0 | 511.01K | 7.61K | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | -30K | 26K | 604K | -611 | 0 | 1.58M | -1.37M | -1.15M |
Cash from Financing | 402.58K | 178.62M | 207.58M | 149.55M | 274K | 194.1M | 6.77M | 587K | 276.18M | 365.97M |
Debt Issued (Net) | -578K | -1.8M | -4.65M | -303K | -582.92K | -474K | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 1M | 151.7M | 208.94M | 149.89M | 978K | 194.59M | 6.77M | 587K | 277.04M | 276.51M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -29.33K | -572.36K | 0 | -563K | 0 | 0 | -154K | -47K | 0 | 0 |
Other Financing | -163.03K | -506.34K | 3.29M | -35K | -121.08K | -20K | 0 | 0 | -854.56K | 89.46M |
Net Change in Cash | -166.93M▲ 0% | -20.65M▲ 87.6% | 52.68M▲ 355.1% | 3.1M▼ 94.1% | -119.05M▼ 3944.1% | 131.9M▲ 210.8% | -67.83M▼ 151.4% | -108.91M▼ 60.6% | 161.71M▲ 248.5% | 216.21M▲ 0% |
Free Cash Flow | -171.53M▲ 0% | -193.23M▼ 12.7% | -153.94M▲ 20.3% | -168.42M▼ 9.4% | -109.16M▲ 35.2% | -56.45M▲ 48.3% | -80.33M▼ 42.3% | -106.81M▼ 33.0% | -121.18M▼ 13.4% | -151.2M▲ 0% |
FCF Margin % | -1489.12% | -1507.87% | -1046.67% | -1493.65% | -1912.4% | -1176.13% | -510.75% | - | - | - |
FCF Growth % | -129.52% | -12.65% | 20.33% | -9.41% | 35.19% | 48.28% | -42.29% | -32.97% | -13.45% | -67.15% |
FCF per Share | -34.64 | -33.40 | -20.80 | -15.57 | -9.91 | -3.65 | -4.22 | -5.55 | -21.71 | -0.00 |
FCF Conversion (FCF/Net Income) | 0.91x | 0.98x | 0.86x | 1.04x | 1.11x | 0.58x | 1.10x | 0.92x | 0.82x | 0.90x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DBVT Key Ratios
DBV Technologies S.A. (DBVT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -78.62% | -109.14% | -95.84% | -80.04% | -64.24% | -65.63% | -43.47% | -135.72% | -150.29% | -130.15% |
Return on Invested Capital (ROIC) | - | -4441.01% | -847.19% | -461.04% | -259.52% | -664.89% | -1067.09% | -2231.7% | - | 1366.34% |
Gross Margin | 100% | 100% | 100% | 100% | -62.46% | -322.9% | 100% | - | - | - |
Net Margin | -1538.29% | -1484.65% | -1169.51% | -1415% | -1713.54% | -2006.25% | -462.4% | - | - | - |
Debt / Equity | 0.04x | 0.03x | 0.14x | 0.08x | 0.11x | 0.02x | 0.05x | 0.28x | 0.13x | 0.00x |
Interest Coverage | -43.46x | -396.92x | -452.53x | -186.87x | -144.25x | -227.12x | - | - | - | -189.82x |
FCF Conversion | 0.91x | 0.98x | 0.86x | 1.04x | 1.11x | 0.58x | 1.10x | 0.92x | 0.82x | 0.90x |
Revenue Growth | 45.31% | 11.25% | 14.77% | -23.33% | -49.38% | -15.91% | 227.67% | -100% | - | -100% |
Related:DBVT Dividend History·DBVT Revenue History·DBVT Price History·DBVT P/E History·DBVT Financial Ratios·DBVT Institutional Holders
DBVT SEC Filings & Documents
DBV Technologies S.A. (DBVT) SEC filings — annual & quarterly reports (10-K, 10-Q)
DBVT Frequently Asked Questions
DBV Technologies S.A. (DBVT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
DBV Technologies S.A. (DBVT) grew revenue by 0.0% over the past year. Growth has been modest.
DBV Technologies S.A. (DBVT) reported a net loss of $167.8M for fiscal year 2025.
Dividend & Returns
DBV Technologies S.A. (DBVT) has a return on equity (ROE) of -150.3%. Negative ROE indicates the company is unprofitable.
DBV Technologies S.A. (DBVT) had negative free cash flow of $151.2M in fiscal year 2025, likely due to heavy capital investments.